Diamond Biofund Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	2,733	2,756	126.23	2,103	333.84	18.14
Short-Term Investments	-	-	3,100	-	-	4.5
Trading Asset Securities	1,003	1,135	1,904	7,544	10,404	10,065
Cash & Short-Term Investments	3,737	3,891	5,130	9,647	10,738	10,087
Cash Growth	-25.99%	-24.15%	-46.82%	-10.16%	6.45%	51.30%
Accounts Receivable	3.93	3.87	-	-	1.87	1.69
Other Receivables	9.31	8.33	7.74	2.64	0.21	-
Receivables	13.24	12.2	7.74	2.64	2.08	1.69
Other Current Assets	3.19	2.91	1.78	6	0.59	0.08
Total Current Assets	3,753	3,906	5,140	9,656	10,741	10,089
Property, Plant & Equipment	85.05	91.56	134.99	124.81	5.7	43.87
Long-Term Investments	5,134	5,340	5,391	3,235	445.28	406.09
Other Intangible Assets	0.12	0.26	0.25	0.14	0.28	-
Long-Term Accounts Receivable	-	11.52	-	-	-	-
Long-Term Deferred Tax Assets	0.03	0.02	-	-	-	-
Other Long-Term Assets	19.57	9.06	9.04	25.77	2.59	83.68
Total Assets	8,992	9,359	10,675	13,042	11,194	10,623
Accounts Payable	-	-	18.91	-	-	-
Current Portion of Leases	25.19	24.81	23.9	15.23	3.67	8.73
Current Income Taxes Payable	-	-	120.68	-	83.26	105.58
Other Current Liabilities	36.43	43.83	44.13	50.73	57.13	83.24
Total Current Liabilities	61.62	68.64	207.62	65.96	144.06	197.55
Long-Term Leases	62.66	69.12	93.93	113.78	-	33.26
Long-Term Deferred Tax Liabilities	0.03	0.02	-	-	-	-
Total Liabilities	124.3	137.79	301.55	179.74	144.06	230.82
Common Stock	8,529	8,528	8,514	8,499	6,350	5,000
Additional Paid-In Capital	2,887	2,886	3,544	3,530	12.75	1.16
Retained Earnings	-2,549	-2,193	-1,685	833.05	4,688	5,391
Shareholders' Equity	8,867	9,221	10,373	12,862	11,050	10,392
Total Liabilities & Equity	8,992	9,359	10,675	13,042	11,194	10,623
Total Debt	87.85	93.93	117.83	129.01	3.67	41.99
Net Cash (Debt)	3,649	3,797	5,012	9,518	10,734	10,045
Net Cash Growth	-26.09%	-24.24%	-47.34%	-11.33%	6.86%	51.82%
Net Cash Per Share	4.28	4.46	5.89	12.22	13.95	12.41
Filing Date Shares Outstanding	852.75	852.75	851.39	849.89	749.3	749.3
Total Common Shares Outstanding	852.75	852.75	851.39	849.89	749.3	749.3
Working Capital	3,692	3,838	4,932	9,590	10,597	9,892
Book Value Per Share	10.40	10.81	12.18	15.13	14.75	13.87
Tangible Book Value	8,867	9,221	10,373	12,862	11,050	10,392
Tangible Book Value Per Share	10.40	10.81	12.18	15.13	14.75	13.87

Source: S&P Global Market Intelligence. Standard template. Financial Sources.